Neximmune, Inc.
Neximmune, Inc.'s email is kcarter@neximmune.com
and
Neximmune, Inc.'s phone number is 3018610009
.
NexImmune is an early stage biopharmaceutical company developing novel immuno-therapeutics based on the proprietary Artificial IMmune (AIMTM) technology. The AIM technology provides an important advance in the development of immunotherapies for a variety of cancers and other diseases. The AIM technology has been designed to orchestrate specific immune system responses in a highly controllable and reproducible way independent of the healthiness or abundance of the patient’s natural antigen presenting cell (APC) population. Natural APCs are major players in the body’s im...
read more
NexImmune is an early stage biopharmaceutical company developing novel immuno-therapeutics based on the proprietary Artificial IMmune (AIMTM) technology. The AIM technology provides an important advance in the development of immunotherapies for a variety of cancers and other diseases. The AIM technology has been designed to orchestrate specific immune system responses in a highly controllable and reproducible way independent of the healthiness or abundance of the patient’s natural antigen presenting cell (APC) population. Natural APCs are major players in the body’s immune system as they direct the immune system cells in attacks on specifically targeted antigens and cells. However, under certain disease conditions, natural APCs can be damaged, absent or inactive.
show less
|
Website | neximmune.com |
|
Industry | Biotechnology |
|
Location | Gaithersburg, Maryland, United States |
|
Employees | 44 |
|
Founded | 2011 |
|
HQ | 22 Firstfield Road Suite 280 |
|
Phone | 301-861-0009 |
|
kcarter@neximmune.com | |
|
Funding | 210,268,293 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Website | neximmune.com |
|
|
Industry | Biotechnology |
|
|
Location | Gaithersburg, Maryland, United States |
|
|
Employees | 44 |
|
|
Founded | 2011 |
|
linkedin.com/company/neximmune-inc. | |
|
|
HQ | 22 Firstfield Road Suite 280 |
|
|
Phone | 301-861-0009 |
|
|
kcarter@neximmune.com | |
|
|
Funding | 210,268,293 USD |
Email Patterns for Neximmune, Inc.
Top Competitors for Neximmune, Inc.
Neximmune, Inc. Questions
Where are Neximmune, Inc.'s headquarters?
Neximmune, Inc.'s headquarters are in 22 Firstfield Road Suite 280
What is Neximmune, Inc.'s phone number?
Neximmune, Inc.'s phone number is 3018610009
What is Neximmune, Inc.'s official website?
Neximmune, Inc.'s website is neximmune.com
How many employees are working in Neximmune, Inc. right now?
Neximmune, Inc. has
44 employees.
View the Email and Phone Numbers for all 44 working at Neximmune, Inc..
What is Neximmune, Inc.'s industry?
Neximmune, Inc.'s industry is
Biotechnology
Who are Neximmune, Inc.'s top competitors?
Neximmune, Inc.'s top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Neximmune, Inc.'s email address?
Neximmune, Inc.'s email address is kcarter@neximmune.com
What are Neximmune, Inc.'s categories?
Neximmune, Inc.'s categories are Biopharma, Biotechnology, Therapeutics
What is Neximmune, Inc.'s location?
Neximmune, Inc.'s location is
Gaithersburg, Maryland, United States
When was Neximmune, Inc.'s founded?
Neximmune, Inc.'s founding year is 2011
What is Neximmune, Inc.'s funding?
Neximmune, Inc.'s funding is 210,268,293 USD
What is Neximmune, Inc.'s current status?
Neximmune, Inc.'s current status is ipo
Top Neximmune, Inc. Employees
Senior Director, Operations
deby.pan@tevausa.com
+1240-821-9096
Senior Scientist, Analytical
melissawinn@gmail.com
+1309-353-7014
Senior Vice President, Molecular Engineering And Protein Design
terribed@aol.com
+1443-864-1445
Chief Operating Officer
kristi.jonesph@gmail.com
+1650-743-4135
Head Of Business Development
matt.schiller@emdserono.com
+1509-599-1660
Manager, Procurement
swhitsett@ix.netcom.com
+1301-806-4489
Director Protein Design
csrj2000@adelphia.net
+1301-293-8910
